Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TCEB1 encodes the protein elongin C, which is a subunit of the transcription factor B (SIII) complex. Additionally we are shipping TCEB1 Proteins (13) and many more products for this protein.
Showing 10 out of 59 products:
Human Polyclonal TCEB1 Primary Antibody for EIA, WB - ABIN955124
Marcsisin, Engen: Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif. in Journal of molecular biology 2010
Show all 5 references for ABIN955124
Human Polyclonal TCEB1 Primary Antibody for WB - ABIN256361
Maine, Mao, Komarck, Burstein: COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase. in The EMBO journal 2007
Show all 5 references for ABIN256361
Dog (Canine) Monoclonal TCEB1 Primary Antibody for IF, IP - ABIN968161
Bradsher, Jackson, Conaway, Conaway: RNA polymerase II transcription factor SIII. I. Identification, purification, and properties. in The Journal of biological chemistry 1994
Show all 2 references for ABIN968161
Chicken Polyclonal TCEB1 Primary Antibody for WB - ABIN2792678
Yu, Yu, Liu, Luo, Kong, Mao, Yu: Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. in Science (New York, N.Y.) 2003
Human Polyclonal TCEB1 Primary Antibody for IHC (p), WB - ABIN658734
Piessevaux, De Ceuninck, Catteeuw, Peelman, Tavernier: Elongin B/C recruitment regulates substrate binding by CIS. in The Journal of biological chemistry 2008
Crystal structure shows interaction between SOCS2 (show SOCS2 Antibodies)-elongin BC and Cullin-5 (show CUL5 Antibodies).
PRAME (show PRAME Antibodies) expression in leukaemic cell lines is upregulated by IFN gamma (show IFNG Antibodies) and LPS (show TLR4 Antibodies), suggesting a possible role in immune responses. PRAME (show PRAME Antibodies) associates with Elongin BC complexes by binding Elongin C.
Elongin B (show TCEB2 Antibodies)/C recruitment regulates substrate binding by CIS (show CISH Antibodies)
SOCS (show CISH Antibodies) box acts as an independent binding domain capable of recruiting elonginBC and cullin5 to promote E3 ligase formation.
TCEB1 promotes invasion of prostate cancer cells and is involved in development of hormone-refractory prostate cancer
crystals of SOCS2 (show SOCS2 Antibodies) in complex with its adaptor proteins, Elongin C and Elongin B (show TCEB2 Antibodies), underwent a change in crystallographic parameters when treated with dimethyl sulfoxide during soaking experiments.
TCEB1-mutated renal cell carcinoma (show MOK Antibodies) is a distinct entity with recurrent hotspot mutations, specific copy number alterations, pathway activation, and characteristic morphological features.
The crystal structure of VHL (show VHL Antibodies) bound to a Cul2 (show CUL2 Antibodies) N-terminal domain, Elongin B (show TCEB2 Antibodies), and Elongin C.
Vif (show BTG1 Antibodies) interaction with EloB (show TCEB2 Antibodies)-EloC may contribute to recruitment of CBF-beta (show CBFB Antibodies) to Vif (show BTG1 Antibodies), demonstrating that the EloB (show TCEB2 Antibodies) C-teminus may play a role in improving Vif (show BTG1 Antibodies) function and that the over-expression of EloB (show TCEB2 Antibodies) results in Vif (show BTG1 Antibodies) stabilization.
AFF1 is a ubiquitous P-TEFb (show CCNT1 Antibodies) partner; full Tat (show TAT Antibodies) transactivation requires the complete super elongation complexes
ASB9 (show ASB9 Antibodies) is unstable alone but forms a stable ternary complex with EloBC that binds with high affinity to the Cullin 5 (show CUL5 Antibodies) N-terminal domain.
PRAME (show PRAME Antibodies) expression in leukaemic cell lines is upregulated by IFN gamma (show IFNG Antibodies) and LPS (show IRF6 Antibodies), suggesting a possible role in immune responses. PRAME (show PRAME Antibodies) associates with Elongin BC complexes by binding Elongin C.
TCEB1 and SELC14L1 are good candidate markers for predicting prognosis and progression of prostate cancer.
Functional interaction of Notch4 (show NOTCH4 Antibodies)(ICD (show GNPTAB Antibodies)) and Elongin C provides novel insight into regulation of Notch (show NOTCH1 Antibodies) signaling in epithelial cell biology and disease.
Recombinant full-length Vif (show BTG1 Antibodies) interacted with the Elongin BC complex in vitro with a K(d) of 1.9 muM and resulted in observable changes in deuterium uptake in both Elongin C and B.
results indicate that antagonistic regulation of gene expression by PAF1Cand p-TEFb (show CCNT1 Antibodies) plays a crucial role in oligodendrocyte development in the CNS.
P-TEFb (show CCNT1 Antibodies) has a role in coupling transcription elongation with alternative splicing, and maintaining core 7SK snRNP (show LSM2 Antibodies) is essential for vertebrate development
This gene encodes the protein elongin C, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been identified.
RNA polymerase II transcription factor SIII subunit C
, SIII p15
, elongin 15 kDa subunit
, elongin C
, stromal membrane-associated protein SMAP1B homolog
, transcription elongation factor B polypeptide 1
, elongation factor SIII p15 subunit
, Elongin C
, transcription elongation factor B (SIII), polypeptide 1